本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kazia Therapeutics Limited

8.57
-1.2500-12.73%
盘后8.990.4200+4.90%16:42 EDT
成交量:7.11万
成交额:65.15万
市值:1,165.18万
市盈率:-0.35
高:10.08
开:9.21
低:8.41
收:9.82
数据加载中...
2025/02/03

SEC问询函

Form CORRESP - Correspondence
2025/01/30

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/11/15

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/11

SEC问询函

Form CORRESP - Correspondence
2024/08/12

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/03

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/27

SEC问询函

Form CORRESP - Correspondence
2024/06/25

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/06/01

SEC问询函

Form CORRESP - Correspondence
2024/05/29

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/03

SEC问询函

Form CORRESP - Correspondence
2024/01/31

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/12/21

SEC问询函

Form CORRESP - Correspondence
2023/10/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/20

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/07

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/09/07

SEC问询函

CORRESP [Cover] - Correspondence